1,25-dihydroxyvitamin D3 -: a hormone with immunomodulatory properties

被引:0
|
作者
Lemire, J [1 ]
机构
[1] Univ Calif San Diego, Dept Pediat, Div Pediat Nephrol, La Jolla, CA 92093 USA
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2000年 / 59卷
关键词
1,25-dihydroxyvitamin D-3; immunosuppression; cytokines; Th1; autoimmunity; transplantation; scleroderma;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The active vitamin D metabolite, 1,25-dihydroxyvitamin DJ [1,25-(OH)(2)D-3], exerts immunosuppressive activity. At a cellular and molecular level, the hormone preferentially targets helper T cell activity (Th1) by inhibiting the secretion of both IL-2 and IFN-gamma by Th1 and by suppressing the secretion pro-Th1 cytokine IL-12 by antigen-presenting cells. The active metabolite further inhibits class II antigen expression and enhances suppressor;activity, In animal models of autoimmunity, 1,25-(OH)(2)D-3 prevents the development of experimental autoimmune encephalomyelitis, reduces the incidence of diabetes, and attenuates murine lupus. The hormone also prolongs graft survival in animal models of transplantation. In humans, non-classical use of 1,25-(OH)(2)D-3 has led to an anti-proliferative effect in psoriasis, antineoplastic effect in prostate cancer, and immunomodulatory effect in scleroderma. The development of less hypercalcemic analogs might open a new therapeutic area for vitamin D-3.
引用
收藏
页码:24 / 27
页数:4
相关论文
共 50 条
  • [31] 1α,25-dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells
    Bessler, Hanna
    Djaldetti, Meir
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (06) : 428 - 432
  • [32] 1,25-Dihydroxyvitamin D3 modulates T cell differentiation and impacts on the production of cytokines from Chinese Han patients with early rheumatoid arthritis
    Hong-yan Wen
    Jing Luo
    Xiao-feng Li
    Dan-dan Wei
    Yang Liu
    Immunologic Research, 2019, 67 : 48 - 57
  • [33] Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D3
    Haghmorad, Dariush
    Yazdanpanah, Esmaeil
    Tavaf, Maryam Jadid
    Zargarani, Simin
    Soltanmohammadi, Azita
    Mahmoudi, Mohammad Bagher
    Mahmoudi, Mahmoud
    NEUROLOGICAL RESEARCH, 2019, 41 (10) : 943 - 957
  • [34] 1,25-dihydroxyvitamin D-3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis
    Cantorna, MT
    Hayes, CE
    DeLuca, HF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7861 - 7864
  • [35] 1α,25-Dihydroxyvitamin D3 counteracts the effects of cigarette smoke in airway epithelial cells
    Zhang, Ruhui
    Zhao, Haijin
    Dong, Hangming
    Zou, Fei
    Cai, Shaoxi
    CELLULAR IMMUNOLOGY, 2015, 295 (02) : 137 - 143
  • [36] EXPERIMENTAL BASIS OF CANCER COMBINATION CHEMOTHERAPY WITH RETINOIDS, CYTOKINES, 1,25-DIHYDROXYVITAMIN D-3, AND ANALOGS
    BOLLAG, W
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 56 (04) : 427 - 435
  • [37] Monocytes from type 2 diabetic patients have a pro-inflammatory profile -: 1,25-Dihydroxyvitamin D3 works as anti-inflammatory
    Giulietti, Annapaula
    van Etten, Evelyne
    Overbergh, Lut
    Stoffels, Katinka
    Bouillon, Roger
    Mathieu, Chantal
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 (01) : 47 - 57
  • [38] Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients
    Cohen, ML
    Douvdevani, A
    Chaimovitz, C
    Shany, S
    KIDNEY INTERNATIONAL, 2001, 59 (01) : 69 - 75
  • [39] Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck
    Walker, David D.
    Reeves, Travis D.
    de Costa, Anna-Maria
    Schuyler, Corinne
    Young, M. Rita I.
    CYTOKINE, 2012, 58 (03) : 448 - 454
  • [40] Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D-3
    Schwende, H
    Fitzke, E
    Ambs, P
    Dieter, P
    JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (04) : 555 - 561